[Treatment of patients with bronchial asthma with autologous blood after preliminary exposure extracorporeally to roentgen radiation].
A therapeutic method including extracorporeal x-ray irradiation of the autoblood of patients with bronchial asthma complicated by cortisone dependence and polyvalent drug intolerance, has been elaborated and clinically tested. The use of this method brings about good short-term results in 90% of cases and good long-term results in 40% of cases (14-38 months). It provides an opportunity to give up corticosteroids in more than 60% of patients and to decrease the hormone dose in the rest of cortisone-dependent patients with bronchial asthma. The above therapeutic method can be used as an independent type of treatment, especially in the presence of polyvalent drug allergy and as an element of multiple modality therapy of bronchial asthma patients. The method was used under inpatient conditions only. No side effects were marked in the course of the clinical trial. To carry out this type of therapy, patients should be thoroughly screened.
D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000188:drug therapy / Q000628:therapy*; D001769:Blood / Q000528:radiation effects*; D001804:Blood Transfusion, Autologous; D003131:Combined Modality Therapy; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged
D005938:Glucocorticoids
Lechenie bol'nykh bronkhial'noĭ astmoĭ autokrov'iu, predvaritel'no podvergnutoĭ vne organizma rentgenovskomu oblucheniiu.